A Comparative Study of the Efficacy of Surfactant Administration through a Thin Intratracheal Catheter and its Administration via an Endotracheal Tube in Neonatal Respiratory Distress Syndrome

Document Type : Original Article

Authors

1 Department of Pediatrics, Shahrekord University of Medical Sciences, Shahrekord, Iran

2 Department of Pediatrics, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

3 Social Determinants of Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

4 Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: The cornerstone of the treatment of respiratory distress syndrome (RDS) is respiratory support and surfactant replacement therapy. The administration of surfactant through a thin intratracheal catheter is one of the methods used to reduce one of the standard technique complications of a surfactant injection (Intubation-Surfactant-Extubation method [INSURE]). The aim of this study was to compare the effectiveness of this method on the treatment of RDS in neonates with one of the INSURE technique.
Methods: In this double blind clinical trial, 104 neonates with RDS were randomly allocated to two groups, one group received surfactant via an endotracheal tube (INSURE) and the other received surfactant without intubation (SWI) via a thin intratracheal catheter. Subsequently the outcomes of the two groups were compared.
Results: The incidence of hypoxemia during surfactant administration was significantly lower in the SWI group (11.5%) than in the INSURE group (28.8% , P< 0.05). no significant difference was observed in the need for intubation and mechanical ventilation during the first 72 hours of life, the duration of mechanical ventilation, the need for nasal continuous positive airway pressure (NCPAP), the need for oxygen, the incidence of bronchopulmonary dysplasia, intraventricular hemorrhage, pulmonary hemorrhage ,and death in the two groups.
Conclusion: Administration of surfactant through a thin intratracheal catheter is a safe and easy technique. This method is as effective as the INSURE method in improving the outcomes of RDS treatment.

Keywords

References

1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-- 2013 update. Neonatology. 2013; 103(4):353-68.
 2. Ceylan A, Gezer S, Demir N, Tuncor O, Peker E, Kirimi E. The importance of administration of early surfactant and nasal continuous positive airway pressure in newborns with respiratory distress syndrome. Turk Pediatr Ars. 2014; 49(3):192-7.
3. Lista G, Castoldi F. Surfactant administration in spontaneous breathing with N-CPAP for RDS. Acta Biomed. 2014; 85(1):35-8.
 4. Kribs A, Hartel C, Kattner E, Vochem M, Kuster H, Moller J, et al. Surfactant without intubation in preterm infants with respiratory distress: First multi-center data. Klin Padiatr. 2010; 222(1):13-7.
5. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007; 357(19): 1946-55.
6. Kribs A, Roll C, Gopel W, Wieg C, Groneck P, Laux R, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015; 169(8):723-30.
7. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants, 2010 update. Neonatology. 2010; 97(4):402-17.
8. Kribs A, Pillekamp F, Hunseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (post menstrual age≤27 weeks). Pediatr Anesth. 2007; 17(4):364-9.
9. Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr. 2015; 15:21.
 10. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminay evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Neonatal Ed. 2011; 96(4):F243-8.
 11. Mohammadizadeh M, Ardestani AG, Sadeghnia AR. Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome. J Res Pharm Pract. 2015; 4(1):31-6.
12. Carlo WA, Ambalavanan N. Respiratory tract disorders. In: Kliegman RM, Stanton BF, Geme ST, Schor NF, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier; 2016. P. 848-67.
13. Kuipers MT, VanderPoll T, Schultz MJ, Wieland CW. Bench-to-bedside review: Damage associated molecular patterns in the onset of ventilatorinduced lung injury. Crit Care. 2011; 15(6):235.
14. Gopel W, Kribs A, Hartel C, Avenarius S, Teig N, Groneck P, et al. Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr. 2015; 104(3):241-6.
 15. Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr. 2014; 103(6): e229-33.
 16. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013; 98(2):F122-6.
17. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013; 131(2):502-9. 18. Mirnia K, Heidarzadeh M, Hosseini MB, Sadeghnia A, Balila M, Ghogazadeh M. Comparison outcome of surfactant administration via tracheal catheterization during spontaneous breathing with InSurE. Med J Islamic World Acad Sci. 2013; 109(1007):1-6.
 19. Heidarzadeh M, Mirnia K, Hoseini MB, Sadeghnia A, Akrami F, Balila M, et al. Surfactant administration via thin catheter during spontaneous breathing: randomised controlled trial in Alzahra hospital. Iran J Neonatol. 2013; 4(2):5-9.
20. Klebermass-Schrehof K, Wald M, Schwindt J, Grill A, Prusa AR, Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013; 103(4):252-8.
 21. Lau CS, Chamberlain RS, Sun S. Less invasive surfactant administration reduces the need for mechanical ventilation in preterm infants: a metaanalysis. Glob Pediatr Health. 2017; 4:1-9.
22. Krajewski P, Chudzik A, Strzałko-Głoskowska B, Gorska M, Kmiecik M, Wieckowska K, et al. Surfactant administration without intubation in preterm infants with respiratory distress syndromeour experiences. J Matern Fetal Neonatal Med. 2015; 28(10):1161-4.
 23. Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques. Neonatology. 2012; 101(4):326-36.
24. Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open- label, randomized, controlled trial. Lancet. 2011; 378(9803):1627-34.
25. Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012; 101(12):1232-9.
 26. Niemarrkt HJ, Kuypers E, Jellema R, Ophelders D, Hutten M, Nikiforou M, et al. Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution and lung compliance in spontaneously breathing preterm lambs. Pediatr Res. 2014; 76(2):166-70.
Iranian Journal of Neonatology
Volume 9, Issue 4
December 2018
Pages 33-40

Files

Share

How to cite

Statistics